Navigation Links
New Strategy Eyed for AIDS Treatment
Date:6/22/2009

Discovery of HIV hiding places may pave way for novel therapies

MONDAY, June 22 (HealthDay News) -- A radical new therapy could improve treatment of people with HIV-AIDS by destroying the viruses circulating in the body as well as those hiding in immune system cells, according to a new study.

A team of American and Canadian researchers have high hopes for a combination of targeted chemotherapy and what's known as highly active anti-retroviral (HAART) treatments.

When HIV viruses hide in immune cells, the researchers explained, existing HAART treatments can't reach them. But the study identified where HIV hides in immune cells and the "stealth" mechanisms that enable the virus to elude existing treatments. This finding could lead to new therapies that are different than current treatments, they said.

"Our results argue in favor of a strategy similar to the one used against leukemia, which is targeted chemotherapy, associated with a targeted immune treatment," study co-leader Dr. Rafick-Pierre Sekaly, a professor at the University of Montreal and scientific director of the Vaccine and Gene Therapy Institute of Florida, said in a university news release. "This would make it possible to destroy the cells containing a virus while giving the immune system time to regenerate with healthy cells."

Another co-leader, Dr. Jean-Pierre Routy, an infection and immunity researcher at the Research Institute of the McGill University Health Centre in Montreal, explained the importance of the finding.

"For the first time, this study proves that the HIV reservoirs are not due to a lack of potency of the antiretroviral drugs but to the virus hiding inside two different types of long-life CD4 memory immune cells," Routy said in the news release. "There are several types of HIV reservoirs, each necessitating a different treatment to eliminate them."

The researchers acknowledged, however, that it will take many more years of work before the finding might lead to new treatments for people with HIV-AIDS.

The study appears in the journal Nature Medicine.

More information

The U.S. National Institute of Allergy and Infectious Diseases has more about HIV-AIDS treatment.



-- Robert Preidt



SOURCE: University of Montreal, news release, June 21, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. AMDL CEO Featured in CEOCFO Magazine; Details Progress on DR-70 International Commercialization Strategy & Confidence in FY2009 Financial Forecast
2. DURECT Appoints Dr. Joseph Stauffer as Chief Medical Officer and Executive Vice President, Corporate Strategy
3. NIAID media availability: New strategy proposed for designing antibody-based HIV vaccine
4. XELR8 Holdings, Inc. Hires Vice President of Strategy and Network Development
5. Alere Executives Present National Health Improvement Strategy to Congressional and Industry Leaders
6. Diplomat Specialty Pharmacy Promotes Rinku A. Patel, PharmD to Vice President, Pharmacy Strategy
7. MDS Announces Strategy to Focus MDS Pharma Services on Early Stage Operations - Discovery Through Phase IIa
8. Sisters of Charity Health System Appoints Orlando L. Alvarez Jr. to Head Physician Strategy and Business Development
9. Cutler to Direct Debt Management Product Strategy at Ontario Systems
10. American College of Physicians Chooses iPublishCentral to Launch its e-Book Strategy
11. American College of Physicians Chooses iPublishCentral to Launch its e-Book Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 New Strategy Eyed for AIDS Treatment
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) ... measures required to build a strong and stable market ... listed on the OTC Markets-pink current trading platform. ... "We are seeing an anomaly in market trading activities ... by the Company, but shareholders and market players as ...
(Date:6/24/2016)... N.C. , June 24, 2016  Consumers ... decisions and regulators/payers have placed more emphasis on ... environment, patient support programs in the pharmaceutical industry ... patients, medications. Consequently, pharmaceutical companies are focusing on ... they are providing products and services that improve ...
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
Breaking Medicine Technology: